Table 1.
Characteristics of the patients
| Parameter | Value |
|---|---|
| Number of patients | 83 |
| Women/men | 78/5 |
| Mean age (range) | 42.7 (21–71) years |
| Mean duration of the disease | 8.9 years |
| Activity of the disease (SLAM) | 4-23 (x = 12.31) |
| Patients in an inactive stage of SLE | 34 (41%) |
| Patients in an active stage of SLE | 49 (59%) |
| Clinical manifestations | |
| Malar rush | 43 (52%) |
| Discoid rash | 6 (7%) |
| Photosensitivity | 64 (77%) |
| Oral ulcers | 6 (7%) |
| Arthralgia | 73 (88%) |
| Serositis | 5 (6%) |
| Renal disorder | 18 (22%) |
| Neurologic disorder | 10 (12%) |
| Hematologic disorder | 55 (66%) |
| Immunologic disorder (anti-dsDNA, anti-Sm) | 13 (16%) |
| SLICC/ACR DI | |
| Patients who obtained 0 point | 50 (60.24%) |
| Patients who obtained >1 point | 33 (39.76%) |
| Damage index—medium; SD | x = 0.67; SD = 1.11 |
| Damages: | |
| Ocular | 6 (18.18%) |
| Neuropsychiatric | 10 (30.3%) |
| Renal | 5 (15.15%) |
| Pulmonary | 0 |
| Cardiovascular | 7 (21.21%) |
| Peripheral vascular | 7 (21.21%) |
| Gastrointestinal | 1 (3.03%) |
| Mucoskeletal | 4 (12.12%) |
| Skin | 3 (9.1%) |
| Other | 0 |